USP 99% Sucralfate CAS 54182-58-0

Sucralfate More Info

Sucralfate is a complex of sulfated sucrose and aluminum hydroxide, developed as a unique gastrointestinal medication with cytoprotective properties. Unlike acid-suppressing agents, sucralfate functions through a distinct mechanism by forming a viscous, adhesive substance that selectively binds to eroded or ulcerated mucosal surfaces. This compound was specifically engineered to create a protective barrier at the site of injury while maintaining minimal systemic absorption. Its chemical structure allows it to interact with proteins in the damaged tissue, forming a stable complex that shields the area from further damage. The development of sucralfate represented an innovative approach to ulcer management by focusing on physical protection rather than altering gastric physiology.

Uses and Applications

The primary application of sucralfate is in the management of gastrointestinal ulcers and inflammation. It is clinically used for the treatment of duodenal ulcers, gastric ulcers, and stress ulcer prophylaxis in hospitalized patients. Additionally, it finds application in managing gastroesophageal reflux disease (GERD) by coating the irritated esophageal mucosa. The medication is also utilized in veterinary medicine for similar indications in companion animals. Sucralfate's unique properties make it particularly valuable for patients who cannot tolerate acid-suppressing medications or require additional mucosal protection. It is typically administered as an oral suspension or tablet, requiring specific timing relative to meals and other medications for optimal efficacy.

Application Market

The market for sucralfate occupies a stable niche within the gastrointestinal pharmaceutical sector. As a generic medication, it maintains consistent demand due to its established safety profile and unique mechanism of action. The market distribution includes both human pharmaceutical and veterinary segments, with formulations available in multiple dosages forms including tablets, suspensions, and paste preparations. Major pharmaceutical markets in North America, Europe, and Asia maintain sucralfate in their formularies, particularly for patients requiring long-term ulcer management or those with specific contraindications to proton pump inhibitors. The product remains economically accessible while serving important therapeutic needs in both hospital and outpatient settings.

Important Considerations

Appropriate administration of sucralfate requires careful attention to dosing schedules and potential interactions. The medication should be taken on an empty stomach, typically one hour before meals and at bedtime, to ensure optimal adhesion to affected areas. Importantly, sucralfate may bind to other medications in the gastrointestinal tract, particularly antibiotics, thyroid hormones, and certain vitamins, necessitating separation of administration by at least two hours. While generally well-tolerated, the aluminum content requires consideration in patients with renal impairment when used long-term. Patients should follow healthcare provider guidance regarding duration of therapy and monitoring parameters. Proper storage conditions should be maintained according to manufacturer specifications to ensure product stability.